This review integrates mechanistic insights with translational advances, outlining how dysregulation of chaperones, autophagy-mitophagy, the ubiquitinproteasome system, and ER stress pathways drive human diseases, while highlighting emerging therapeutic platforms, from pharmacological chaperones and autophagy modulators to targeted protein degradation technologies, CRISPR screens, spatial biology, and AI-guided drug discovery
it is not intended to diagnose, treat, cure, or prevent any disease
This isn't just a minor correlationit suggests that boosting these depleted levels could help restore natural energy production
In addition, an infinite variety of combinations or mixtures of solutions can be used to produce endosclerosis